Sungjun Beck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sungjun Beck has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Algis Jasinskas
University of California Irvine
1 shared publication - D. Huw Davies
Adeline Mah Vaccine Center, Department of Physiology & Biophysics, University of California Irvine, Irvine, USA
1 shared publication - Delia F. Tifrea
Department of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, CA 92697, USA
1 shared publication - Jenny Hernandez-Davies
Department of Physiology and Biophysics, University of California, Irvine, CA 92697, USA
1 shared publication - Nader Bigdeli
Student Health Center, University of California, Irvine, CA 92697, USA
1 shared publication - Per Niklas Hedde
University of California, Irvine
1 shared publication
Latest Publications
- Open Access
- 9 September 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (9) , 2238
A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance
High-throughput and rapid screening testing is highly desirable to effectively combat the rapidly evolving COVID-19 pandemic co-presents with influenza and seasonal common cold epidemics. Here, we present a general workflow for iterative development and validation of an antibody-based microarray assay for the detection of a respiratory viral panel: (a) antibody screening to quickly identify optimal reagents and assay conditions, (b) immunofluorescence assay design including signal amplification for low viral titers, (c) assay characterization with recombinant proteins, inactivated viral samples and clinical samples, and (d) multiplexing to detect a panel of common respiratory viruses. Using RT-PCR-confirmed SARS-CoV-2 positive and negative pharyngeal swab samples, we demonstrated that the antibody microarray assay exhibited a clinical sensitivity and specificity of 77.2% and 100%, respectively, which are comparable to existing FDA-authorized antigen tests. Moreover, the microarray assay is correlated with RT-PCR cycle threshold (Ct) values and is particularly effective in identifying high viral titers. The multiplexed assay can selectively detect SARS-CoV-2 and influenza virus, which can be used to discriminate these viral infections that share similar symptoms. Such protein microarray technology is amenable for scale-up and automation and can be broadly applied as a both diagnostic and research tool.
- 9 September 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (9) , 2238
Open AccessA Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance
High-throughput and rapid screening testing is highly desirable to effectively combat the rapidly evolving COVID-19 pandemic co-presents with influenza and seasonal common cold epidemics. Here, we present a general workflow for iterative development and validation of an antibody-based microarray assay for the detection of a respiratory viral panel: (a) antibody screening to quickly identify optimal reagents and assay conditions, (b) immunofluorescence assay design including signal amplification for low viral titers, (c) assay characterization with recombinant proteins, inactivated viral samples and clinical samples, and (d) multiplexing to detect a panel of common respiratory viruses. Using RT-PCR-confirmed SARS-CoV-2 positive and negative pharyngeal swab samples, we demonstrated that the antibody microarray assay exhibited a clinical sensitivity and specificity of 77.2% and 100%, respectively, which are comparable to existing FDA-authorized antigen tests. Moreover, the microarray assay is correlated with RT-PCR cycle threshold (Ct) values and is particularly effective in identifying high viral titers. The multiplexed assay can selectively detect SARS-CoV-2 and influenza virus, which can be used to discriminate these viral infections that share similar symptoms. Such protein microarray technology is amenable for scale-up and automation and can be broadly applied as a both diagnostic and research tool.